Genotype-dependent activity in HCV replicon cells
Cell-based study · HCV luciferase-linked replicons: genotypes 1b, 1a and 2a; stable genotype 1b ET cells derived from Huh7 [1]
Activity differed by genotype. WST-1 cytotoxicity was measured alongside replication; it is not a clinical safety endpoint.
| Endpoint | Reported result | Reference |
|---|---|---|
| Genotype 1b replication | mean EC50 310 nM | [1] |
| Genotype 1a replication | mean EC50 560 nM | [1] |
| Genotype 2a replication | EC50 > 50 µM | [1] |
| Cellular cytotoxicity | mean CC50 > 50 µM | [1] |
Literature-Reported Treatment Conditions
- Exposure duration
- 48 h for the stable genotype 1b assay (§2.4)
- Method
- Compound exposure; reporter response compared with no-compound control.
- Vehicle
- DMSO; final percentage not specified for the stable assay
- Reported limits
- Genotype 1a/2a protocol details are not separately specified in the reviewed assay section. Figure 1B illustrates a different concentration range from §2.4; no unified range assigned.
Methods and source locations
Compound reported in the paper: Anguizole; Compound label in the paper: Chemical Block A2828/0119446
Compound-level evidence; no validation of an Adooq lot.
§2.2; §2.4; §3.1; Figure 1A–B and caption
Genotype 1b replication: Luciferase reporter — §3.1; Figure 1B and caption
Genotype 1a replication: Luciferase reporter — §3.1
Genotype 2a replication: Luciferase reporter; highest concentration tested — §3.1
Cellular cytotoxicity: WST-1 — §3.1; Figure 1 caption